We publish what we know.
Including the limitations.
Patient education articles, condition research summaries, and protocol breakdowns — all written or reviewed against published, peer-reviewed evidence.
MSC Therapy and Infertility: Supporting Reproductive Health Through Regenerative Medicine
Infertility affects approximately 15% of couples worldwide. MSC therapy is being investigated across several aspects of reproductive failure: premature ovarian insufficiency (POI), thin endometrium, poor IVF response, and…
Read Article ?
MSC Therapy for Fatty Liver Disease (NAFLD/NASH): Targeting the Progression to Cirrhosis
Non-alcoholic fatty liver disease (NAFLD) affects an estimated 25% of the global adult population and represents a spectrum from simple steatosis (fat accumulation) to non-alcoholic steatohepatitis (NASH) to…
MSC Therapy for Degenerative Disc Disease: Can Stem Cells Support Spinal Disc Health?
Degenerative disc disease (DDD) involves the breakdown of intervertebral discs — the cushioning structures between vertebrae. As discs degenerate, inflammatory cytokines (TNF-α, IL-1β, IL-6) accumulate, contributing to pain,…
MSC Therapy and Post-Treatment Lyme Disease Syndrome: Addressing Persistent Inflammation
Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted through tick bites. While most cases resolve with antibiotics, a significant subset of patients experience Post-Treatment Lyme Disease…
MSC Therapy for POTS: Targeting Dysautonomia Through Nerve Repair and Immune Modulation
Postural Orthostatic Tachycardia Syndrome (POTS) is a complex dysautonomia characterized by an abnormal increase in heart rate upon standing — typically ≥30 bpm — accompanied by symptoms including…
Hashimoto's Thyroiditis and MSC Therapy: Addressing the Autoimmune Attack on the Thyroid
Hashimoto's thyroiditis is the most common autoimmune thyroid disorder, in which the immune system mistakenly attacks the thyroid gland, causing chronic inflammation, progressive thyroid tissue destruction, and eventually…
MSC Therapy for Sjögren's Syndrome: Targeting Glandular Destruction at the Source
Sjögren's syndrome is a systemic autoimmune disease primarily affecting the salivary and lacrimal (tear) glands, causing chronic dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca). It can also…
Alpha-Gal Syndrome and MSC Therapy: A New Angle on Tick-Induced Immune Sensitization
Alpha-gal syndrome (AGS) is a unique allergic condition characterized by a delayed hypersensitivity reaction to mammalian-derived foods. It develops after exposure to specific tick bites, which introduce a…
MSC Therapy for Hair Loss: The Science Behind Follicle Regeneration
Hair loss — whether androgenetic alopecia (male/female pattern), alopecia areata (autoimmune), or post-inflammatory hair loss — involves either follicle miniaturization, immune-mediated follicle destruction, or disruption of the hair…
MSC Therapy and Heart Disease: Evidence for Cardiac Repair and Anti-Inflammatory Benefit
Cardiovascular disease (CVD) — including coronary artery disease, heart failure, and post-myocardial infarction cardiomyopathy — represents the leading cause of mortality worldwide. Inflammation drives atherosclerotic plaque development, ischemic…
MSC Therapy and Chronic Kidney Disease: Protecting Renal Function Through Anti-Fibrosis
Chronic kidney disease (CKD) progresses through inflammation and fibrosis — the gradual replacement of functional kidney tissue with scar tissue. Conventional management slows progression but cannot reverse existing…
MSC Therapy in Type 1 Diabetes: Protecting and Supporting Beta-Cell Function
Type 1 diabetes (T1D) is an autoimmune disease in which the immune system destroys the insulin-producing beta cells of the pancreas. Once destroyed, beta cells do not regenerate…
MSC Therapy and Autism Spectrum Disorder: What the Preliminary Research Shows
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with heterogeneous presentations. Growing evidence implicates neuroinflammation, immune dysregulation, and mitochondrial dysfunction in ASD pathophysiology — biological targets where…
MSC Therapy After Traumatic Brain Injury: Supporting Recovery Beyond the Acute Phase
Traumatic brain injury (TBI) is caused by a sudden external force disrupting normal brain function. Outcomes range from brief concussion to permanent cognitive and motor impairment. The secondary…
MSC Therapy for Peripheral Neuropathy: Targeting Nerve Damage at its Source
Peripheral neuropathy — damage to the nerves outside the brain and spinal cord — produces symptoms ranging from burning pain and numbness to weakness and loss of coordination.…
MSC Therapy for Longevity: What the Science Says About Cellular Aging
Biological aging is increasingly understood not as a passive process but as a consequence of specific cellular mechanisms: accumulation of senescent cells, mitochondrial dysfunction, chronic low-grade inflammation ('inflammaging'),…
Mesenchymal Stem Cells and COPD: Targeting the Inflammatory Cycle in Lung Disease
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation due to a combination of small airway disease and emphysema — destruction of alveolar walls. The underlying…
MSC Therapy and Type 2 Diabetes: Addressing the Insulin Resistance Mechanism
Type 2 diabetes (T2D) is a metabolic disorder characterized by insulin resistance and progressive beta-cell dysfunction. Chronic inflammation is now recognized as a central driver of both insulin…
Can MSC Therapy Aid Stroke Recovery? The Research on Neuroregeneration
Stroke is the leading cause of long-term disability worldwide. When blood flow to the brain is interrupted, neurons die rapidly — but the post-stroke brain also undergoes a…
MSC Stem Cell Therapy for Osteoarthritis: From Mechanism to Clinical Outcomes
Osteoarthritis (OA) is the most common joint disorder worldwide, characterized by progressive cartilage degradation, subchondral bone changes, synovitis, and chronic pain. Conventional management — NSAIDs, corticosteroids, hyaluronic acid…
MSC Therapy for Rheumatoid Arthritis: Rethinking the Approach to Autoimmune Joint Disease
Rheumatoid arthritis (RA) is a systemic autoimmune disease in which the immune system attacks the synovial joints, causing chronic inflammation, cartilage degradation, and — over time — joint…
MSC Stem Cell Therapy in Parkinson's Disease: Mechanisms and Evidence
Levodopa works. That is not in dispute — for most people with Parkinson's it works well, and often for years. The trouble is what it does not do.…
MSC Stem Cell Therapy and Multiple Sclerosis: What the Research Shows
If you have MS, you already know what the standard drugs do and don't do. They can slow the disease down. They can stretch out the time between…
Ready to find out if
MSC therapy is right for you?
A dedicated coordinator reviews your case and answers every question — before you commit to anything.